Jennifer L. McNeer to Remission Induction
This is a "connection" page, showing publications Jennifer L. McNeer has written about Remission Induction.
Connection Strength
0.288
-
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group. J Clin Oncol. 2019 04 01; 37(10):780-789.
Score: 0.149
-
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. J Clin Oncol. 2019 08 10; 37(23):2072-2081.
Score: 0.038
-
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 04; 33(4):884-892.
Score: 0.036
-
Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leuk Lymphoma. 2018 10; 59(10):2360-2368.
Score: 0.035
-
Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship. Cancer. 2016 Mar 15; 122(6):954-61.
Score: 0.030